Category Specific RSS

mnd

Strategic win for Control Bionics as new HCPCS gets approved for NeuroNode

The Centers for Medicare & Medicaid Services has approved a new Healthcare Common Procedure Coding System code for the NeuroNode,…

1 year ago

PharmAust completes dosing first cohort for MND treatment, patients respond positively

Every day, two people are diagnosed in Australia with a form of motor neurone disease (MND). MND entails a group…

3 years ago

PharmAust shrinks proprietary tablet for use in COVID-19 trials

Good things come in small packages, like PharmAust’s (ASX: PAA) newest iteration of their monepantel (MPL) tablets.  The clinical stage…

4 years ago

PharmAust receives ethics approval just in time for Big Freeze

There is nothing fun about plunging into freezing cold ice water during a cold Melbourne winter. However, each year, bold…

4 years ago

Control Bionics to grow accessibility tech for the disabled with $15m IPO

Technology company, Control Bionics Limited (Proposed ASX: CBL) are one of the latest medtech companies looking to list on the…

5 years ago